The Women’s Health Therapeutics Market is witnessing significant growth due to increasing awareness of gender-specific healthcare needs and investment in women-focused medical research. The market, which includes products and treatments for conditions unique to women such as reproductive health disorders, menopause, osteoporosis, and hormonal imbalances, is driven by the growing prevalence of women’s health disorders, advancements in biotechnology, and introduction of innovative treatment modalities. Conditions including breast cancer, endometriosis, and polycystic ovary syndrome (PCOS) have increased demand for advanced therapeutic solutions. The market is also shaped by emerging trends such as personalised medicine, digital health technologies, non-hormonal therapies, and fertility preservation strategies like egg-freezing and in-vitro fertilisation (IVF). Despite challenges such as underrepresentation of women in clinical trials and access disparities, the market’s potential for growth and innovation remains vast, particularly in areas like fertility care, contraception, and menopause management.